Primary Care Respiratory Society Members Promotion
FeNO predicts the likelihood of steroid responsiveness more consistently than spirometry, bronchodilator response, peak flow variation, or airway hyperresponsiveness to methacholine.1-3
In the Winter 2018 Issue 16 of the PCRU, the regular feature “Second Opinion” discussed the question: “I want to know more about FeNO and whether we should introduce it in our practice. Where can I find out more about it and how do I create a business case in support of its use?”
Recently, the PCRS and Circassia have agreed to a mutually beneficial arrangement which enables Circassia to offer PCRS members a discounted price for NIOX VERO® FeNO testing products. Provision of this member discount does not imply PCRS is endorsing NIOX products. Please quote your PCRS membership number at the time of placing the order.
Read white papers and publications on NIOX VERO Review an overview of clinical guideline to interpretation of FeNO levels